Clinical Trials
21 trialsNCT06834126 2025-07-18
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
City of Hope Medical Center
Phase 1 Recruiting
NCT04406857 2025-02-26
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT04942626 2025-02-21
ACO/ARO/AIO-21
Goethe University
Phase 1 Completed
NCT03916510 2025-02-06
CEDAR
University of Oxford
Phase 1 Completed
NCT03300544 2024-05-23
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT01769222 2024-01-24
Ipilimumab and Local Radiation for Selected Solid Tumors
Stanford University
Phase 1 Terminated
NCT01740648 2023-09-18
Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT02910843 2023-01-10
RECAP
Swiss Cancer Institute
Phase 1 Terminated
NCT03297710 2023-01-05
TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery
Mayo Clinic
Phase 1 Completed
NCT02935309 2022-05-31
Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT01134601 2021-12-01
A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT01197664 2018-07-02
Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery
Wake Forest University Health Sciences
Phase 1 Terminated
NCT00003704 2016-07-06
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 1 Completed
NCT02137356 2015-09-03
Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Sheba Medical Center
Phase 1 Unknown
NCT00543842 2015-02-26
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00002801 2013-12-19
Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00960427 2013-04-16
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn
NCT00003799 2013-01-10
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00280176 2012-02-14
Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT01474187 2011-11-18
Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer
Fudan University
Phase 1 Unknown
NCT00084591 2010-02-12
Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
Fox Chase Cancer Center
Phase 1 Completed